Company intelligence / Profile preview
Rose Pharma
Copenhagen, Denmarkrosepharmainc.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Phase II double-blinded placebo controlled trial in Europe demonstrated efficacy for IBS pain treatment, and a phase I/II trial in the US established safety in IBS patients with predominant constipation[2]
- Therapeutic areas
- GastroenterologyMetabolic DisordersOncology
- Modalities
- Peptide hormonesGLP-1 analogues
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Eli Lilly and Company (licensing agreement since 2008)[2]
Beyond the preview
Go deeper on Rose Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rose Pharma.